214 related articles for article (PubMed ID: 29859926)
1. E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.
Yang L; Jin L; Ke Y; Fan X; Zhang T; Zhang C; Bian H; Wang G
J Invest Dermatol; 2018 Dec; 138(12):2568-2577. PubMed ID: 29859926
[TBL] [Abstract][Full Text] [Related]
2. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
[TBL] [Abstract][Full Text] [Related]
3. Keratin 17 as a therapeutic target for the treatment of psoriasis.
Fu M; Wang G
J Dermatol Sci; 2012 Sep; 67(3):161-5. PubMed ID: 22795618
[TBL] [Abstract][Full Text] [Related]
4. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
[TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.
Liu L; Wu Y; Cao K; Xu YY; Gao XH; Chen HD; Geng L
Int J Clin Exp Pathol; 2015; 8(8):9202-7. PubMed ID: 26464667
[TBL] [Abstract][Full Text] [Related]
6. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2.
Zhang W; Dang E; Shi X; Jin L; Feng Z; Hu L; Wu Y; Wang G
PLoS One; 2012; 7(7):e40797. PubMed ID: 22808266
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17.
Yang L; Fan X; Cui T; Dang E; Wang G
J Invest Dermatol; 2017 Oct; 137(10):2168-2176. PubMed ID: 28576737
[TBL] [Abstract][Full Text] [Related]
8. TGFβ/SMAD/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis.
Jiang M; Sun Z; Dang E; Li B; Fang H; Li J; Gao L; Zhang K; Wang G
J Invest Dermatol; 2017 Oct; 137(10):2177-2186. PubMed ID: 28642156
[TBL] [Abstract][Full Text] [Related]
9. Keratin 17: a critical player in the pathogenesis of psoriasis.
Jin L; Wang G
Med Res Rev; 2014 Mar; 34(2):438-54. PubMed ID: 23722817
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
[TBL] [Abstract][Full Text] [Related]
12. Upregulated E3 ligase tripartite motif-containing protein 21 in psoriatic epidermis ubiquitylates nuclear factor-κB p65 subunit and promotes inflammation in keratinocytes.
Yang L; Zhang T; Zhang C; Xiao C; Bai X; Wang G
Br J Dermatol; 2021 Jan; 184(1):111-122. PubMed ID: 32232831
[TBL] [Abstract][Full Text] [Related]
13. Effect of Calcipotriol on IFN-γ-Induced Keratin 17 Expression in Immortalized Human Epidermal Keratinocyte Cells.
Zhang J; Fang H; Wang R; Dang E; Jiang M; Wang G
Med Sci Monit; 2017 Dec; 23():6049-6056. PubMed ID: 29269725
[TBL] [Abstract][Full Text] [Related]
14. Anti-psoriatic properties of paeoniflorin: suppression of the NF-kappaB pathway and Keratin 17.
Bai X; Yu C; Yang L; Luo Y; Zhi D; Wang G; Dang E
Eur J Dermatol; 2020 Jun; 30(3):243-250. PubMed ID: 32576538
[TBL] [Abstract][Full Text] [Related]
15. WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17.
Ti C; Chen H; Zhou W; Bian A; Hu P; Miao Y; Shao T; Liu M; Chen Y; Yi Z
Int Immunopharmacol; 2024 Jan; 127():111344. PubMed ID: 38086269
[TBL] [Abstract][Full Text] [Related]
16. Regulation of epidermal expression of keratin K17 in inflammatory skin diseases.
Komine M; Freedberg IM; Blumenberg M
J Invest Dermatol; 1996 Oct; 107(4):569-75. PubMed ID: 8823363
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
Bockelmann R; Horn T; Gollnick H; Bonnekoh B
Skin Pharmacol Physiol; 2005; 18(1):42-54. PubMed ID: 15608502
[TBL] [Abstract][Full Text] [Related]
18. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
[TBL] [Abstract][Full Text] [Related]
19. Keratin 17 in disease pathogenesis: from cancer to dermatoses.
Yang L; Zhang S; Wang G
J Pathol; 2019 Feb; 247(2):158-165. PubMed ID: 30306595
[TBL] [Abstract][Full Text] [Related]
20. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]